Refugee patients receive different psychiatric medications than native Swedes

A Swedish study finds that refugees experiencing first-episode psychosis are treated with different antipsychotic drugs than their Swedish-born counterparts. The disparity raises concerns about healthcare equity and treatment outcomes, with potential implications for mental health policy and pharmaceutical guidance across immigrant populations.

Originaltitel: Antipsychotic treatment patterns in refugees and their Swedish-born peers with first-episode non-affective psychosis: findings from the REMAIN study